These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8412574)

  • 21. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression.
    Salín-Pascual RJ; Rosas M; Jimenez-Genchi A; Rivera-Meza BL; Delgado-Parra V
    J Clin Psychiatry; 1996 Sep; 57(9):387-9. PubMed ID: 9746444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II.
    Griffith NM; Szaflarski JP; Szaflarski M; Kent GP; Schefft BK; Howe SR; Privitera MD
    Epilepsy Behav; 2005 Sep; 7(2):266-72. PubMed ID: 16005686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic role of rubidium in psychiatric research.
    Williams RH; Maturen A; Sky-Peck HH
    Compr Ther; 1987 Sep; 13(9):46-54. PubMed ID: 3311597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal tolerance of rubidium chloride: short-term clinical evaluation.
    Tuoni M; Marchitiello M; Paternoster G; Gerace S; Palla R; Placidi GF; Lenzi A; Toschi D; Meltzer HL
    J Clin Pharmacol; 1987 Jul; 27(7):503-7. PubMed ID: 3655002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of rubidium chloride on the course of manic-depressive illness.
    Paschalis C; Jenner FA; Lee CR
    J R Soc Med; 1978 May; 71(5):343-52. PubMed ID: 349155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of depressive mood and vegetative symptoms during treatment with L-tryptophan.
    Siddiqui AR; Stein MB
    J Clin Psychopharmacol; 1986 Apr; 6(2):118-9. PubMed ID: 3700696
    [No Abstract]   [Full Text] [Related]  

  • 31. Rubidium chloride ingestion by volunteer subjects: initial experience.
    Fieve RR; Meltzer HL; Taylor RM
    Psychopharmacologia; 1971; 20(4):307-14. PubMed ID: 5561654
    [No Abstract]   [Full Text] [Related]  

  • 32. [Presence of a radioactive isotope in rubidium, a potential antidepressant presently undergoing clinical trial (author's transl)].
    Strolin Benedetti M; Faure G; Raynaud G; Donath A
    Nouv Presse Med; 1979 Feb; 8(7):529. PubMed ID: 111223
    [No Abstract]   [Full Text] [Related]  

  • 33. Rubidium: overview and clinical perspectives.
    Fieve RR; Jamison KR
    Mod Probl Pharmacopsychiatry; 1982; 18():145-63. PubMed ID: 7048073
    [No Abstract]   [Full Text] [Related]  

  • 34. Rubidium: biochemical, behavioral, and metabolic studies in humans.
    Fieve RR; Meltzer H; Dunner DL; Levitt M; Mendlewicz J; Thomas A
    Am J Psychiatry; 1973 Jan; 130(1):55-61. PubMed ID: 4682749
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Rubidium in psychiatry.
    Soucek K; Krulík R
    Act Nerv Super (Praha); 1975; 17(4):261-2. PubMed ID: 1221787
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium and rubidium: a role in the affective disorders.
    Platman SR
    Dis Nerv Syst; 1971 Sep; 32(9):604-6. PubMed ID: 5000097
    [No Abstract]   [Full Text] [Related]  

  • 37. Rubidium replacement of total body potassium in humans.
    Gwirtsman HE; Meltzer HL; Dunner DL; Fieve RR; Pierson RN
    Horm Metab Res; 1980 Apr; 12(4):175. PubMed ID: 7390398
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrolyte metabolism in patients with periodic affective disorders during treatment with rubidium.
    Jenner FA; Lee CR; Paschalis C; Hill SE; Burkinshaw L; Jennings G
    Psychopharmacology (Berl); 1983; 81(4):301-9. PubMed ID: 6419259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lofepramine and psychomotor function.
    Hindmarch I
    Int Clin Psychopharmacol; 1988 Nov; 3 Suppl 2():71-7. PubMed ID: 3063747
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kinetics and bioavailability of rubidium chloride].
    Rutigliano G; Cerfeda S; Margari F
    Clin Ter; 1980 Sep; 94(6):679-86. PubMed ID: 7460502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.